Exit Text Mode

Macular Disease Foundation Australia logo

    Refer to us

    MDFA provides free information, guidance and support to people living with macular disease.

    Man looking at letters on an eye chart

    You can refer yourself or have your healthcare provider refer to us via this e-referral form.

    If you don’t have easy access to all the information required in the form below, please contact MDFA’s National Helpline on 1800 111 709 or via Email on [email protected].

      Referrer’s details

      Please tell us a little about you as the person providing the referral. This helps us when we connect with your patient or client.





      Referrer type

      Macula Matters


      Patient/client details

      Please ask your patient/client to agree to this statement:

      I agree for this practice to provide my personal information (name, contact details, information about my eye health) to Macular Disease Foundation Australia so that MDFA can contact me with information about macular disease and MDFA’s services.

      First name
      Last name
      Address
      Suburb
      State/Territory
      Postcode
      Email

      Please provide at least one contact number*:

      Phone

      Mobile

      Does this person require an interpretor?:
      Please tell us which language
      If other, please state:


      Comments:


      Newsletter signup

        Patient/client details

        Please read and agree to the below statement:

        I agree to provide my personal information (name, contact details, information about my eye health) to Macular Disease Foundation Australia so that MDFA can contact me with information about macular disease and MDFA’s services.

        First name
        Last name
        Address
        Suburb
        State/Territory
        Postcode
        Email

        Please provide at least one contact number*:

        Phone

        Mobile

        Does this person require an interpretor?:
        Please tell us which language
        If other, please state:


        Comments:


        Newsletter signup

        Loading...